Innate Pharma SA (FR:IPH)
PARIS:IPH
Holding FR:IPH?
Track your performance easily

Innate Pharma SA (IPH) Balance Sheet

2 Followers

Innate Pharma SA Balance Sheet

Innate Pharma SA's total assets for Q4 2023 were $184.21M, a decrease of -11.38% from the previous quarter. FR:IPH total liabilities were $132.29M for the fiscal quarter, a -15.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 184.21M$ 207.86M$ 267.50M$ 307.42M$ 401.36M
Total Liabilities
$ 132.29M$ 156.44M$ 133.74M$ 153.61M$ 185.28M
Total Equity Gross Minority
$ 51.90M$ 54.15M$ 107.44M$ 155.98M$ 217.42M
Total Capitalization
$ 82.86M$ 379.64M$ 375.22M$ 372.13M$ 369.62M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Innate Pharma SA Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis